Literature DB >> 9079690

Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu.

R Worthylake1, H S Wiley.   

Abstract

The epidermal growth factor receptor (EGF-R) is known to transmodulate the activity and level of the erbB-2/neu protein in several epithelial cell lines. We therefore determined which structural features of the EGF-R were important in transmodulating erbB-2. We found that the addition of EGF to nontransformed epithelial cells resulted in down-regulation of erbB-2 with the same kinetics and similar extent as the EGF-R. By using cells expressing a series of EGF-R modified by site-directed mutagenesis, we found that EGF-R tyrosine kinase activity was not necessary for down-regulation of erbB-2, but receptor sequences between 899 and 958 in the EGF-R were required. To determine whether transmodulation was associated with activation of erbB-2, tyrosine phosphorylation of erbB-2 was determined following addition of EGF. Again, phosphorylation of erbB-2 following EGF addition did not require the intrinsic tyrosine kinase activity of the EGF-R, but did require sequences between 899 and 958. To determine the localization of EGF-R and erbB-2 following EGF addition, the relative distribution of the two receptors was evaluated by fluorescence microscopy. Surprisingly, the majority of erbB-2 was found in small cytoplasmic vesicles, whereas the EGF-R was predominantly found on the cell surface. Addition of EGF resulted in a redistribution and consequent colocalization of both receptors in endosomal and lysosomal structures. We conclude that activation and transmodulation of erbB-2 does not require intrinsic tyrosine kinase activity of the EGF-R, but does require sequences in the EGF-R which regulate its trafficking.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9079690     DOI: 10.1074/jbc.272.13.8594

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.

Authors:  Matthew Zeglinski; Ana Ludke; Davinder S Jassal; Pawan K Singal
Journal:  Exp Clin Cardiol       Date:  2011

2.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.

Authors:  P Burke; K Schooler; H S Wiley
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

3.  Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.

Authors:  Z Wang; L Zhang; T K Yeung; X Chen
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

4.  NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.

Authors:  A E Sirica; S Radaeva; N Caran
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

5.  Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.

Authors:  G C Huang; X Ouyang; R J Epstein
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Authors:  A E Lenferink; R Pinkas-Kramarski; M L van de Poll; M J van Vugt; L N Klapper; E Tzahar; H Waterman; M Sela; E J van Zoelen; Y Yarden
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

7.  HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms.

Authors:  Bart S Hendriks; H Steven Wiley; Douglas Lauffenburger
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

8.  Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis.

Authors:  Toshimitsu Yamaoka; Fang Yan; Hanwei Cao; Stuart S Hobbs; Rebecca S Dise; Wei Tong; D Brent Polk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-13       Impact factor: 11.205

9.  The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure.

Authors:  Jonathan R Walker; Pawan K Singal; Davinder S Jassal
Journal:  Exp Clin Cardiol       Date:  2009

Review 10.  Endocytosis and intracellular trafficking of ErbBs.

Authors:  Alexander Sorkin; Lai Kuan Goh
Journal:  Exp Cell Res       Date:  2008-08-28       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.